Enabling and leading commercialization and industry partnerships for a healthier world, Commercialization at UHN is the research commercialization hub based at the University Health Network in Toronto. We are the catalyst for accelerating UHN’s world-class research discoveries towards maximum patient impact globally.
Technologies discovered, developed and de-risked at UHN form the basis of products and services improving health care for patients internationally, including therapeutics, devices and diagnostics. In many cases, these represent the foundational platforms for a number of successful companies first incubated within UHN.
The ex-vivo lung perfusion keeps lungs alive outside the body prior to transplant, dramatically increasing the availability of donor lungs and doubling the lung transplant rate—and lives saved—at UHN.Learn More
Note: Latest fiscal year, unless otherwise stated; all figures in CAD
Commercial success of our most promising innovations and clinical capabilities
And retain world-class commercialization talent at UHN
UHN commercialization expertise has enabled the creation of new companies founded on UHN technologies and collaborations. These companies are now making an impact on health care around the world.
Drs. Heather Ross and Joseph A. Cafazzo were named 2022 joint Inventors of the Year for revolutionizing cardiac care through Medly, a digital health solution for heart health care from anywhere. Medly reduces heart failure management costs and hospitalizations by 50% and forms the basis of a new UHN venture, Medly Therapeutics, poised to bring heart care benefits to patients around the world.View Past Winners
Proudly sponsored by Commercialization at UHN, the UHN Inventor of the Year Award recognizes an inventor or team who has made a substantial and noteworthy contribution to developing healthcare innovations with high commercialization potential.
Do you think your medical innovation is a contender?